title: Is decavanadate a specific inositol 1,4,5-trisphosphate receptor antagonist?
authors.forename: J
authors.initials: J
authors.lastname: Strupish
authors.forename: R J
authors.initials: RJ
authors.lastname: Wojcikiewicz
authors.forename: R A
authors.initials: RA
authors.lastname: Challiss
authors.forename: S T
authors.initials: ST
authors.lastname: Safrany
authors.forename: A L
authors.initials: AL
authors.lastname: Willcocks
authors.forename: B V
authors.initials: BV
authors.lastname: Potter
authors.forename: S R
authors.initials: SR
authors.lastname: Nahorski
mesh_terms: D000302:Adrenal Cortex / Q000378:metabolism; D000818:Animals; D015220:Calcium Channels; D002460:Cell Line; D002531:Cerebellum / Q000378:metabolism; D006801:Humans; D015544:Inositol 1,4,5-Trisphosphate / Q000378:metabolism*; D053496:Inositol 1,4,5-Trisphosphate Receptors; D007700:Kinetics; D011956:Receptors, Cell Surface / Q000187:drug effects* / Q000378:metabolism; D018160:Receptors, Cytoplasmic and Nuclear; D014638:Vanadates / Q000494:pharmacology*
chemical_list: D015220:Calcium Channels; C506926:ITPR1 protein, human; D053496:Inositol 1,4,5-Trisphosphate Receptors; D011956:Receptors, Cell Surface; D018160:Receptors, Cytoplasmic and Nuclear; D014638:Vanadates; D015544:Inositol 1,4,5-Trisphosphate